Maravai Lifesciences Holdings (MRVI) Net Cash Flow (2020 - 2026)

Maravai Lifesciences Holdings' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$51.0 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 36.29% year-over-year to -$51.0 million; the TTM figure through Mar 2026 stood at -$119.1 million (up 56.97% YoY), while the FY2025 annual figure was -$105.5 million, up 58.24% from the prior year.
• Net Cash Flow was -$51.0 million for Q1 2026 at Maravai Lifesciences Holdings, down from -$26.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $119.2 million in Q2 2022 to a low of -$255.8 million in Q4 2024.
• Historically, Net Cash Flow has averaged -$22.7 million across 5 years, with a median of -$13.3 million in 2024.
• Biggest YoY gain for Net Cash Flow was 973.2% in 2024; the steepest drop was 5408.46% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $14.7 million in 2022, then plunged by 131.6% to -$4.6 million in 2023, then plunged by 5408.46% to -$255.8 million in 2024, then soared by 89.56% to -$26.7 million in 2025, then tumbled by 91.02% to -$51.0 million in 2026.
• The last three Net Cash Flow figures came in at -$51.0 million (Q1 2026), -$26.7 million (Q4 2025), and -$26.3 million (Q3 2025), per Business Quant data.